Engineering and design software provider PTC (NASDAQ:PTC) reported Q4 CY2024 results beating Wall Street’s revenue ...

Engineering and design software provider PTC (NASDAQ:PTC) will be reporting earnings tomorrow afternoon. Here’s what to ...

Below is Validea's guru fundamental report for PTC INC (PTC). Of the 22 guru strategies we follow, PTC rates highest using our P/B Growth Investor model based on the published strategy of Partha ...

Shares of PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Free Report) shot up 6.1% during trading on Monday after Cantor Fitzgerald raised their price target on the stock from $76.00 to $113.00. Cantor ...

Executive Panel Discussion to Highlight the Impact of AI and the Future of Digital Infrastructure The views and opinions expressed herein are the views and opinions of the author and do not ...

Inc., a leading provider of software solutions for product design, manufacturing, and service, continues to navigate a challenging macroeconomic environment while positioning itself for future growth.

$80,000 of PTC THERAPEUTICS INC. lobbying was just disclosed, from Q4 of 2024, in a new Lobbying Disclosure Act filing. This included lobbying on issues like: "Issues related to access to rare ...

Simulations Plus (SLP) came out with quarterly earnings of $0.17 per share, missing the Zacks Consensus Estimate of $0.18 per share. This compares to earnings of $0.10 per share a year ago.

PTC Therapeutics, Inc. (NASDAQ:PTCT), a biopharmaceutical company focused on developing and commercializing novel medicines for rare disorders, finds itself at a critical juncture. With a promising ...

PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Free Report) has earned a consensus rating of “Hold” from the fifteen research ...

PTC Inc. (NASDAQ:PTC – Get Free Report) has been assigned an average recommendation of “Moderate Buy” from the thirteen ratings firms that are presently covering the firm, Marketbeat Ratings ...